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an excellent correlation with OCT, demonstrating a slightly higher
correlation coefﬁcient compared to conventional 40MHz IVUS
(Figure 1). Scaffold ISA was identiﬁed by OCT in 14 cross-sections; 11
of them were also detected by 60MHz HD-IVUS. In contrast, 40MHz
IVUS detected only 2 ISA sites, attributable to unclear images of
BRS struts and/or blood speckles behind the ISA struts (Figure 2).
Strut fracture was identiﬁed by OCT in 2 cross-sections; all of
them were clearly detected by 60MHz HD-IVUS, while 40MHz
IVUS showed ambiguous detection of this entity (Figure 3). These
ﬁndings were also conﬁrmed on high-speed pullback images of
60MHz HD-IVUS.CONCLUSIONS The 60MHz HD-IVUS is superior to conventional
40MHz IVUS in both quantitative and qualitative evaluation of BRS
without the need for blood removal from the imaging ﬁeld. Our
ﬁndings suggest the novel 60MHz HD-IVUS as a well-balanced clinical
imaging system with respect to image resolution, signal penetration
and ease of image acquisition procedure.
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BACKGROUND Chronic kidney disease is an independent risk factor
for adverse coronary events. Pathological studies suggest a unique
and high-risk atherosclerotic phenotype in such patients. Concor-
dant data using in-vivo, high-resolution intravascular imaging with
optical coherence tomography, however, remains limited. OCT with
its high resolution (20 mm) is capable to accurately identify
macrophage content and microvessels in coronary plaques. The aim
of this study was to characterize the differences in coronary
atherosclerotic culprit lesions in patients with versus without
chronic kidney disease (CKD) Using Optical Coherence Tomography
(OCT).
METHODS We analyzed 380 culprit lesions from 380 patients From
Mount Sinai Hospital (MSH) optical coherence tomography imaging
database. Estimated glomerular ﬁltration rate (eGFR) was calculated
using Modiﬁcation of Diet in Renal Disease formula (MDRD) and
CKD was deﬁned as an eGFR of 60 ml/min/1.73m2. OCT was
performed in patients undergoing catheterization of culprit lesion.
Images were analyzed systematically at 1 mm intervals according topreviously validated criteria using St. Jude Medical Ofﬂine Review
Workstation.
RESULTS Compared to patients without (n¼317, mean eGFR 88.7 
23.6) those with (n¼63, mean eGFR 50.3  9.3) CKD were older, more
often males with a greater burden of hypertension and dyslipidemia
as published in previous studies. CKD lesions had signiﬁcantly
longer lipid pools (6.975.67 vs 5.38  4.63mm p ¼ 0.018), increased
macrophages (81% vs 65% p ¼ 0.009) as well as a trend to higher
microvessels (59% vs 45% p ¼ 0.051). However, Fibrous cap thick-
ness, and TCFA were not signiﬁcantly different between the two
groups.CONCLUSIONS Using OCT we demonstrate that even mild renal
impairment is associated with several pathological determinants of
plaque vulnerability, such as plaque inﬂammation and neo-
vascularization. These ﬁndings might contribute to atherosclerosis
and plaque rupture and thus increased cardiovascular risk in patients
with CKD.
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BACKGROUND Optical coherence tomography (OCT) allows precise
evaluation of coronary structures. There is limited knowledge
whether plaque burden plays a role in coronary healing response, or is
susceptible to antiproliferative drugs or stents after PCI. We aimed to
implement a 3-dimensional OCT algorithm to analyze and quantify
atherosclerotic plaques in stented vessel segments. Furthermore, we
investigated intracoronary plaque burden among two different stent
types and at two different time points.
METHODS 52 de-novo lesions in 43 patients (N ¼ 35 males, 69.5 
7.6 yrs) with stable CAD were treated with stent implantation (BMS
or DES). Six-month OCT analysis was available in 44 lesions, and
earlier 2-month OCT f/u in 16 lesions. A novel, 3-dimensional al-
gorithm was applied to calculated plaque burden (Figure). Plaque
morphology was assessed according to international consensus in
OCT imaging.
RESULTS After 6-months, we found comparable plaque volumes and
plaque surface areas in both stent groups (N ¼ 25 BMS: plaque volume
10.1  10.3 mm3, plaque area 16.8  14.1 mm2 vs. N ¼ 19 DES: plaque
volume 11.9  15.7 mm3, plaque area 15.5  20.6 mm2, n.s.). No asso-
ciation between neointimal proliferation or stent malapposition/stent
coverage and global plaque burden within the stented vessel seg-
ments was found. However, there was a signiﬁcantly greater plaque
burden 6-months compared to 2 months after elective PCI (Plaque
volume: 10.09  10.28 mm3 vs. 3.14  3.89 mm3 , p ¼ 0.004; plaque
surface area: 16.81  14.11 mm2 vs. 6.0  7.47 mm2, p ¼ 0.003).
B148 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5Intracoronary plaques were visualized by a “spread-vessel-chart” in
relation to their position within the stent and their morphology (color-
coded, Figure).CONCLUSIONS (1) This novel 3D OCT plaque analysis is feasible, and
allows comprehensive evaluation and quantiﬁcation of intracoronary
plaques and their spatial relationship with adjacent structures (e.g.
stent struts, side branches, thrombi). (2) Coronary stent placement did
not stop atherosclerotic plaque progression in this small patient
group.
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BACKGROUND Intravascular Ultrasound (IVUS)-derived plaque
burden (PB) is a powerful predictor of major adverse cardiovascular
events (MACE). While OCT provides histology-grade deﬁnition of
coronary plaque morphology in vivo, it does not allow for direct
assessment of PB due to limited depth penetration. The value of OCT
for the estimation of plaque burden has not been investigated.
Accordingly, we sought to identify OCT-derived correlates of IVUS PB
and to assess the diagnostic accuracy of OCT in detecting lesions with
large plaque burden (PB 70%).
METHODS We retrospectively analyzed a total of 110 consecutive
patients with stable coronary disease who underwent optical coher-
ence tomography (OCT), IVUS, and near infrared spectroscopy (NIRS)
before their percutaneous coronary intervention (PCI). Culprit lesions
were divided according to IVUS-derived PB 70% (PB Large; n¼86)
and lesions with PB<70% (PB small; n¼24).RESULTS Simultaneous OCT analysis showed increased maximum
lipid arcs (220.100 vs. 118.450, P < 0.01), longer lipid pools (8.00 mm
vs. 2.00 mm, P < 0.032); greater lipid volume index [averaged lipid
arc  lipid length] (991.79 vs. 179.57, P < 0.002), thinner ﬁbrous caps
(80.00 mm vs. 110.00 mm, P < 0.009), smaller minimum lumen cross
sectional area (1.62 mm2 vs. 2.13 mm2, P¼0.002), and a higher lumen
area stenosis (72% vs. 60%, P¼0.001). Lipid volume index, lipid
length, minimum cap thickness, and maximum lipid arc in combina-
tion with lumen area stenosis had signiﬁcant strong association with
IVUS plaque burden by multivariate linear regression analysis
(R2¼0.445, 0.432, 0.393, 0.336 correspondingly). Best accuracy for the
detection of PB Large was achieved using maximum lipid arc ¼ 144.60
(area under the curve (AUC) ¼ 0.806; SS¼84%, SP¼75%), and lumen
area stenosis ¼ 69.2% (AUC ¼ 0.764; SS¼66%, SP¼83%) as cutoff
values.
CONCLUSIONS OCT characteristics of the lipid core size (maximum
arc, length, lipid volume index) and lumen area stenosis provide the
strongest correlation with IVUS plaque burden.
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